360° phototherapy versus single-surface LED phototherapy with white curtains in neonatal hyperbilirubinaemia: a randomised controlled trial

INTRODUCTION: Neonatal hyperbilirubinaemia is a common condition encountered globally with potential complications such as bilirubin encephalopathy. Phototherapy remains the standard treatment due to its accessibility and effectiveness. This study compares the efficacy of 360° phototherapy versus single-surface LED phototherapy with a white curtain in managing neonatal hyperbilirubinaemia requiring intensive phototherapy. METHODS: A randomised controlled trial was conducted at Hospital Pakar Universiti Sains Malaysia from December 2022 to March 2023 involving 40 neonates requiring intensive phototherapy within the first week of life. Participants were randomised into two groups: an intervention group that received 360° phototherapy ( n = 20) and a control group that received single-surface LED phototherapy with a white curtain ( n = 20). The primary outcome was the mean reduction in serum bilirubin at 4 h, 10 h and 24 h of phototherapy, which was analysed using repeated measures analysis of variance and the log-rank test. Secondary outcomes included phototherapy-related side effects and device ease of use among nurses from the neonatal intensive care unit. RESULTS: Both phototherapy methods significantly reduced serum bilirubin levels over 24 h ( P < 0.001). The 360° phototherapy group showed greater reduction at 4 h (27 ± 6.13 μmol/L, P < 0.001) than the control group (2.61 ± 6.3 μmol/L, P = 0.616). The log-rank test showed a significant difference in phototherapy duration ( P = 0.005). At 24 h, the proportion that required phototherapy was 0 for the 360° phototherapy group and 0.05 for the control group (χ 2 = 7.6, degrees of freedom = 1, P = 0.005, hazard ratio 2.29, 95% confidence interval 1.17-4.51). Safety profiles were comparable. Most nurses reported no difficulty using the 360° device. CONCLUSION: 360° phototherapy achieves therapeutic goals more rapidly with a comparable safety profile.

Authors

Institutions

Publication Details

Journal
Singapore Medical Journal
Published
2026-04-17
DOI
https://doi.org/10.4103/singaporemedj.smj-2025-070
Primary Topic
Neonatal Health and Biochemistry
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

360° phototherapy versus single-surface LED phototherapy with white curtains in neonatal hyperbilirubinaemia: a randomised controlled trial

Nor Rosidah Ibrahim, Hans Van Rostenberghe, Noraida Ramli, Nik Amalia Nik Najib
Singapore Medical Journal
Neonatal Health and Biochemistry
article

360° phototherapy versus single-surface LED phototherapy with white curtains in neonatal hyperbilirubinaemia: a randomised controlled trial

Nor Rosidah Ibrahim, Hans Van Rostenberghe, Noraida Ramli, Nik Amalia Nik Najib
article en

Abstract

INTRODUCTION: Neonatal hyperbilirubinaemia is a common condition encountered globally with potential complications such as bilirubin encephalopathy. Phototherapy remains the standard treatment due to its accessibility and effectiveness. This study compares the efficacy of 360° phototherapy versus single-surface LED phototherapy with a white curtain in managing neonatal hyperbilirubinaemia requiring intensive phototherapy. METHODS: A randomised controlled trial was conducted at Hospital Pakar Universiti Sains Malaysia from December 2022 to March 2023 involving 40 neonates requiring intensive phototherapy within the first week of life. Participants were randomised into two groups: an intervention group that received 360° phototherapy ( n = 20) and a control group that received single-surface LED phototherapy with a white curtain ( n = 20). The primary outcome was the mean reduction in serum bilirubin at 4 h, 10 h and 24 h of phototherapy, which was analysed using repeated measures analysis of variance and the log-rank test. Secondary outcomes included phototherapy-related side effects and device ease of use among nurses from the neonatal intensive care unit. RESULTS: Both phototherapy methods significantly reduced serum bilirubin levels over 24 h ( P < 0.001). The 360° phototherapy group showed greater reduction at 4 h (27 ± 6.13 μmol/L, P < 0.001) than the control group (2.61 ± 6.3 μmol/L, P = 0.616). The log-rank test showed a significant difference in phototherapy duration ( P = 0.005). At 24 h, the proportion that required phototherapy was 0 for the 360° phototherapy group and 0.05 for the control group (χ 2 = 7.6, degrees of freedom = 1, P = 0.005, hazard ratio 2.29, 95% confidence interval 1.17-4.51). Safety profiles were comparable. Most nurses reported no difficulty using the 360° device. CONCLUSION: 360° phototherapy achieves therapeutic goals more rapidly with a comparable safety profile.

Singapore Medical Journal
Management and Science University (MY), Universiti Sains Malaysia (MY), Hospital Universiti Sains Malaysia (MY)
Good health and well-being
Openalex Percentile: Top 17%
Neonatal Health and Biochemistry
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.